1. Home
  2. NMS vs VERU Comparison

NMS vs VERU Comparison

Compare NMS & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMS
  • VERU
  • Stock Information
  • Founded
  • NMS 1993
  • VERU 1971
  • Country
  • NMS United States
  • VERU United States
  • Employees
  • NMS N/A
  • VERU N/A
  • Industry
  • NMS Finance Companies
  • VERU Biotechnology: Pharmaceutical Preparations
  • Sector
  • NMS Finance
  • VERU Health Care
  • Exchange
  • NMS Nasdaq
  • VERU Nasdaq
  • Market Cap
  • NMS 71.8M
  • VERU 75.1M
  • IPO Year
  • NMS N/A
  • VERU 1990
  • Fundamental
  • Price
  • NMS $12.30
  • VERU $0.45
  • Analyst Decision
  • NMS
  • VERU Strong Buy
  • Analyst Count
  • NMS 0
  • VERU 4
  • Target Price
  • NMS N/A
  • VERU $4.00
  • AVG Volume (30 Days)
  • NMS 12.0K
  • VERU 1.8M
  • Earning Date
  • NMS 01-01-0001
  • VERU 05-07-2025
  • Dividend Yield
  • NMS 4.11%
  • VERU N/A
  • EPS Growth
  • NMS N/A
  • VERU N/A
  • EPS
  • NMS N/A
  • VERU N/A
  • Revenue
  • NMS N/A
  • VERU $16,886,419.00
  • Revenue This Year
  • NMS N/A
  • VERU N/A
  • Revenue Next Year
  • NMS N/A
  • VERU $30.16
  • P/E Ratio
  • NMS N/A
  • VERU N/A
  • Revenue Growth
  • NMS N/A
  • VERU 22.46
  • 52 Week Low
  • NMS $9.21
  • VERU $0.45
  • 52 Week High
  • NMS $12.18
  • VERU $1.92
  • Technical
  • Relative Strength Index (RSI)
  • NMS 37.62
  • VERU 34.48
  • Support Level
  • NMS $12.35
  • VERU $0.49
  • Resistance Level
  • NMS $12.40
  • VERU $0.51
  • Average True Range (ATR)
  • NMS 0.07
  • VERU 0.04
  • MACD
  • NMS -0.01
  • VERU 0.00
  • Stochastic Oscillator
  • NMS 0.00
  • VERU 0.07

About NMS Nuveen Minnesota Quality Municipal Income Fund

Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Share on Social Networks: